Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Engraftment syndrome after autologous peripheral blood stem cell transplantation with high numbers of peripheral blood stem cells followed by granulocyte colony-stimulating factor administration

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. To LB, Haylock DN, Simmons PL et al. The biology and clinical uses of blood stem cells Blood 1997 89: 2233–2258

    CAS  Google Scholar 

  2. Salazar R, Sola C, Marto P et al. Factors affecting CD34+ cell mobilization with with cyclophosphamide and G-CSF and haematopoietic recovery after high-dose chemotherapy and stem cell support in solid tumour patients Proc ASCO 1998 17: 95a

    Google Scholar 

  3. Lee CK, Gingrich, RD, Hohl RJ, Ajram-KA . Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation Bone Marrow Transplant 1995 16: 175–182

    CAS  PubMed  Google Scholar 

  4. Ravoet C, Feremans W, Husson B et al. Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation Bone Marrow Transplant 1996 18: 943–947

    CAS  PubMed  Google Scholar 

  5. Rabitsch W, Staudinger T, Brugger SA et al. Successful management of adult respiratory distress syndrome (ARDS) after high-dose chemotherapy and peripheral blood progenitor cell rescue by non-invasive ventilatory support Bone Marrow Transplant 1998 21: 1067–1069

    Article  CAS  Google Scholar 

  6. Niitsu N, Iki S, Muroi K et al. Interstitial pneumonia in patients receiving granulocyte colony-stimulating factor during chemotherapy: survey in Japan 1991–96 Br J Cancer 1997 76: 1661–1666

    Article  CAS  Google Scholar 

  7. Ohsaka A, Kitagawa S, Sakamoto S et al. In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma Blood 1989 74: 2743–2748

    CAS  PubMed  Google Scholar 

  8. Ericson SG, Zhao Y, Gao H et al. Interleukin-6 production by human neutrophils after Fc-receptor cross-linking or exposure to granulocyte colony-stimulating factor Blood 1998 91: 2099–2107

    CAS  PubMed  Google Scholar 

  9. Colby C, McAfee SL, Finkelstein, DM et al. Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantation Bone Marrow Transplant 1998 21: 1005–1010

    Article  CAS  Google Scholar 

  10. Kawano Y, Takaue Y, Mimaya J et al. Marginal benefit/disadvantage of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in children: results of a prospective randomized trial. The Japanese Cooperative Study Group of PBSCT Blood 1998 92: 4040–4046

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kawano, C., Muroi, K., Kuribara, R. et al. Engraftment syndrome after autologous peripheral blood stem cell transplantation with high numbers of peripheral blood stem cells followed by granulocyte colony-stimulating factor administration. Bone Marrow Transplant 25, 228–229 (2000). https://doi.org/10.1038/sj.bmt.1702110

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702110

This article is cited by

Search

Quick links